HomeCompareHOLX vs BKR

HOLX vs BKR: Dividend Comparison 2026

HOLX yields 2.65% · BKR yields 1.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BKR wins by $6.8K in total portfolio value· pulled ahead in Year 4
10 years
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →
BKR
BKR
● Live price
1.52%
Share price
$60.68
Annual div
$0.92
5Y div CAGR
27.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.4K
Annual income
$2,429.16
Full BKR calculator →

Portfolio growth — HOLX vs BKR

📍 BKR pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOLXBKR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOLX + BKR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOLX pays
BKR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
BKR
Annual income on $10K today (after 15% tax)
$128.87/yr
After 10yr DRIP, annual income (after tax)
$2,064.79/yr
At 15% tax rate, BKR beats the other by $1,797.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOLX + BKR for your $10,000?

HOLX: 50%BKR: 50%
100% BKR50/50100% HOLX
Portfolio after 10yr
$27.0K
Annual income
$1,371.59/yr
Blended yield
5.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BKR right now

HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
BKR
Analyst Ratings
31
Buy
13
Hold
1
Sell
Consensus: Buy
Price Target
$60.80
+0.2% upside vs current
Range: $52.00 — $68.00
Altman Z
2.6
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOLX buys
0
BKR buys
0
No recent congressional trades found for HOLX or BKR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOLXBKR
Forward yield2.65%1.52%
Annual dividend / share$2.00$0.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%27.4%
Portfolio after 10y$23.6K$30.4K
Annual income after 10y$314.03$2,429.16
Total dividends collected$2.9K$9.0K
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusHoldBuy
Analyst price target$77.80$60.80

Year-by-year: HOLX vs BKR ($10,000, DRIP)

YearHOLX PortfolioHOLX Income/yrBKR PortfolioBKR Income/yrGap
1$10,965$264.73$10,893$193.16+$72.00HOLX
2$12,004$271.27$11,906$250.53+$98.00HOLX
3$13,121$277.55$13,066$326.03+$55.00HOLX
4← crossover$14,323$283.54$14,406$425.99$83.00BKR
5$15,615$289.27$15,974$559.25$359.00BKR
6$17,003$294.73$17,830$738.33$827.00BKR
7$18,493$299.93$20,060$981.27$1.6KBKR
8$20,093$304.87$22,778$1,314.43$2.7KBKR
9$21,809$309.57$26,150$1,777.14$4.3KBKR
10$23,649$314.03$30,410$2,429.16$6.8KBKR

HOLX vs BKR: Complete Analysis 2026

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →

BKREnergy

Baker Hughes Company provides a portfolio of technologies and services to energy and industrial value chain worldwide. It operates through four segments: Oilfield Services (OFS), Oilfield Equipment (OFE), Turbomachinery & Process Solutions (TPS), and Digital Solutions (DS). The OFS segment offers exploration, drilling, wireline, evaluation, completion, production, and intervention services; and drilling and completions fluids, wireline services, downhole completion tools and systems, wellbore intervention tools and services, pressure pumping systems, oilfield and industrial chemicals, and artificial lift technologies for oil and natural gas, and oilfield service companies. The OFE segment provides subsea and surface wellheads, pressure control and production systems and services, flexible pipe systems for offshore and onshore applications, and life-of-field solutions, including well intervention and decommissioning solutions; and services related to onshore and offshore drilling and production operations. The TPS segment provides equipment and related services for mechanical-drive, compression, and power-generation applications across the oil and gas industry. Its product portfolio includes drivers, compressors, and turnkey solutions; and pumps, valves, and compressed natural gas and small-scale liquefied natural gas solutions. This segment serves upstream, midstream, downstream, onshore, offshore, and industrial customers. The DS segment provides sensor-based process measurements, machine health and condition monitoring, asset strategy and management, control systems, as well as non-destructive testing and inspection, and pipeline integrity solutions. The company was formerly known as Baker Hughes, a GE company and changed its name to Baker Hughes Company in October 2019. Baker Hughes Company is based in Houston, Texas.

Full BKR Calculator →
📬

Get this HOLX vs BKR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOLX vs SCHDHOLX vs JEPIHOLX vs OHOLX vs KOHOLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.